510(k) K183128
K183128 is an FDA 510(k) premarket notification submitted by Abbott for the device "EnSite Velocity Cardiac Mapping System v5.2, EnSite Precision Cardiac Mapping System v2.2". The FDA issued a decision of Substantially Equivalent on December 12, 2018. The device falls under product code DQK (Computer, Diagnostic, Programmable), a Class II device regulated under 21 CFR 870.1425. Abbott has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 12, 2018
- Date Received
- November 13, 2018
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Computer, Diagnostic, Programmable
- Device Class
- Class II
- Regulation Number
- 870.1425
- Review Panel
- CV
- Submission Type